OxyDial Inc

OxyDial Inc

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://oxydial.com/

Last Round

Seed Round

May 20, 2026

Total Funding Raised

$1.95M

Company Overview

OxyDial Inc is a medical technology company that develops an oxygen-hemoglobin equilibrium blood testing instrument and a cloud platform intended for research and medical purposes, with a focus on blood disorders like Sickle Cell Disease.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

OEC testingOECOxygen-Hemoglobin Equilibrium Curveportable blood testingSCDSickle Cell Diseasemedtechclinical research toolspoint-of-care testingbiotech equipmentlife science toolsblood disordersresearch use onlyhealthcare analyticsmedical device SaaSathletic performance testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OxyDial Inc Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OxyDial Inc Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMay 20, 2026
SeedMar 17, 2026
AcceleratorJun 16, 2025
SeedMay 22, 2023

Key People

Founding team and executive leadership

Alex Aprelev

Co-Founder, CTO

Founding Team

Olek Shestakov

Co-Founder & CEO

Founding Team

OxyDial Inc Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    $700K raised in Seed Round.

  • Mar 17, 2026

    $1.5M round with participation from Capital Factory and Science Center.

OxyDial Inc Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OxyDial Inc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OxyDial Inc's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range16
Year Founded2022
Last FundingMay 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.